Why is Terumo Corp. ?
- Healthy long term growth as Net Sales has grown by an annual rate of 12.52%
- Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 36.60
- The company has been able to generate a Return on Capital Employed (avg) of 11.10% signifying high profitability per unit of total capital (equity and debt)
- OPERATING CASH FLOW(Y) Highest at JPY 272,691 MM
- ROCE(HY) Highest at 10.85%
- NET SALES(Q) Highest at JPY 311,810 MM
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -11.58%, its profits have risen by 2.2% ; the PEG ratio of the company is 8.7
How much should you buy?
- Overall Portfolio exposure to Terumo Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Terumo Corp. for you?
Low Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at JPY 272,691 MM
Highest at 10.85%
Highest at JPY 311,810 MM
Fallen by -2.37% (YoY
Highest at JPY 595,195 MM
Highest at 1.73 times
Highest at 5.76 times
Highest at JPY 96,030 MM
Highest at 30.8 %
Highest at JPY 90,384 MM
Highest at JPY 70,426 MM
Highest at JPY 47.73
Here's what is working for Terumo Corp.
Operating Cash Flows (JPY MM)
Net Sales (JPY MM)
Operating Profit (JPY MM)
Operating Profit to Sales
Pre-Tax Profit (JPY MM)
Pre-Tax Profit (JPY MM)
Net Profit (JPY MM)
Net Profit (JPY MM)
EPS (JPY)
Cash and Cash Equivalents
Inventory Turnover Ratio
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Depreciation (JPY MM)






